Ebola virus (EBOV) disease can result in a range of symptoms anywhere from virtually asymptomatic to severe hemorrhagic fever during acute infection. Additionally, spans of asymptomatic persistence in recovering survivors is possible, during which transmission of the virus may occur. In acute infection, substantial cytokine storm and bystander lymphocyte apoptosis take place, resulting in uncontrolled, systemic inflammation in affected individuals. Recently, studies have demonstrated the presence of EBOV proteins VP40, glycoprotein (GP), and nucleoprotein (NP) packaged into extracellular vesicles (EVs) during infection. EVs containing EBOV proteins have been shown to induce apoptosis in recipient immune cells, as well as contain pro-inflammatory cytokines. In this manuscript, we review the current field of knowledge on EBOV EVs including the mechanisms of their biogenesis, their cargo and their effects in recipient cells. Furthermore, we discuss some of the effects that may be induced by EBOV EVs that have not yet been characterized and highlight the remaining questions and future directions.
Keywords: Ebola virus; GP; NP; VP40; cytokine; exosome; extracellular vesicles.
Conflict of interest statement
Disclaimer: The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the US Department of the Army, the US Department of Defense, the US Department of Health and Human Services, or of the institutions and companies affiliated with the authors.
Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.Front Microbiol. 2016 Nov 7;7:1765. doi: 10.3389/fmicb.2016.01765. eCollection 2016. Front Microbiol. 2016. PMID: 27872619 Free PMC article.
Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.Version 2. J Infect Dis. 2018 Nov 22;218(suppl_5):S365-S387. doi: 10.1093/infdis/jiy472. J Infect Dis. 2018. PMID: 30169850 Free PMC article.
Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.J Clin Microbiol. 2016 Dec 28;55(1):165-176. doi: 10.1128/JCM.01979-16. Print 2017 Jan. J Clin Microbiol. 2016. PMID: 27795350 Free PMC article.
The Role of Exosomal VP40 in Ebola Virus Disease.DNA Cell Biol. 2017 Apr;36(4):243-248. doi: 10.1089/dna.2017.3639. Epub 2017 Feb 8. DNA Cell Biol. 2017. PMID: 28177658 Free PMC article. Review.
The lifecycle of the Ebola virus in host cells.Oncotarget. 2017 Jun 15;8(33):55750-55759. doi: 10.18632/oncotarget.18498. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903457 Free PMC article. Review.
Cited by 2 articles
Expression of microRNA in human retinal pigment epithelial cells following infection with Zaire ebolavirus.BMC Res Notes. 2019 Oct 1;12(1):639. doi: 10.1186/s13104-019-4671-8. BMC Res Notes. 2019. PMID: 31570108 Free PMC article.
Serum-Derived Extracellular Vesicles from African Swine Fever Virus-Infected Pigs Selectively Recruit Viral and Porcine Proteins.Viruses. 2019 Sep 20;11(10):882. doi: 10.3390/v11100882. Viruses. 2019. PMID: 31547130 Free PMC article.
- WHO Ebola Outbreak 2014–2015. [(accessed on 7 January 2019)]; Available online: http://www.who.int/csr/disease/ebola/en/
- Ebola Ebola Situation Reports: Democratic Republic of the Congo. [(accessed on 7 January 2019)]; Available online: http://www.who.int/ebola/situation-reports/drc-2018/en/
- WHO Ebola Virus Disease—Democratic Republic of the Congo. [(accessed on 1 August 2018)]; Available online: http://www.who.int/csr/don/25-july-2018-ebola-drc/en/
- R21 AI074410/AI/NIAID NIH HHS/United States
- R21 AI078859/AI/NIAID NIH HHS/United States
- R01 AI043894/AI/NIAID NIH HHS/United States
- AI127351-01/NH/NIH HHS/United States
- NS099029/NH/NIH HHS/United States